Tazobactam

Evidence Level: N/A Predicted Indications: 0

Table of Contents

  1. Tazobactam
    1. Pharmacist Assessment Report
    2. Tazobactam: Known uses and market status in Canada
    3. Summary
    4. Quick overview
    5. Known uses among the model’s candidates
      1. Approved (supported by a licence or label)
      2. Related to an approved indication (same disease category)
      3. Relations recorded in the knowledge graph (no approval found)
    6. Canada Market Information
    7. Safety Considerations
    8. Disclaimer

Pharmacist Assessment Report

Tazobactam: Known uses and market status in Canada

Summary

The TxGNN deep-learning model (score ≥ 0.99) produced candidates for Tazobactam, but every candidate that can be traced to a source is already a known use. There is therefore currently no new predicted indication for this drug. The known uses are listed below with their sources.

Quick overview

Item Content
New predicted indications None (all traceable model candidates are known uses)
Known uses among model candidates 2
Evidence level Not applicable
Canada Market Status Marketed (marketed DINs: 17 of 17)
Number of DINs 17 (marketed: 17)

Known uses among the model’s candidates

Approved (supported by a licence or label)

Indication Source
pneumonia licence in another country; approved indication: hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). consideration should be given to official guidance on the appropriate use of antibacterial agents
Indication Approved category
urinary tract infection (disease) urinary tract infection

Relations recorded in the knowledge graph (no approval found)

Indication
none

Canada Market Information

Licence Product Dosage form Status
02402068 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02446901 ZERBAXA   Valid
02377748 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02528703 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02362627 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02521539 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02362619 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02528711 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02299623 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02362635 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02402084 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02439131 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02402076 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02528673 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02330547 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02299631 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid
02299658 PIPERACILLIN AND TAZOBACTAM FOR INJECTION   Valid

Safety Considerations

Label warnings and contraindications were not available. Please refer to the package insert for safety information.

The following comes from the TxGNN knowledge graph (disease-level contraindication links, not label text). Diseases linked to tazobactam as contraindications or cautions include:

  • Kidney disease
  • Neutropenia and agranulocytosis
  • Blood coagulation disease
  • Clostridium difficile colitis
  • Perinatal necrotizing enterocolitis
  • Pyoureter
  • Infectious mononucleosis and chronic Epstein-Barr virus infection syndrome

No drug interaction records were found.


Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.



This site uses Just the Docs, a documentation theme for Jekyll.